Compressive Elastic Dressing Versus TR Band (Band Vs Gauze)

September 27, 2022 updated by: Yunis Daralammouri, An-Najah National University

Comparison Between Compressive Elastic Dressing and Hemostatic TR Band Following Cardiac Intervention Utilizing the Radial Technique: A Randomized Controlled Trial

Radial approach is widely established in cardiac diagnostic and therapeutic treatments. It has been shown to decrease bleeding, vascular problems, and mortality rates when compared to the femoral approach. It also offers better comfort to patients through early mobility and lowers hospital expenses.

Previously, there were no specific devices for radial artery hemostasis. Many different types of dressings were used in various hospitals with no standardization. This raises the question of whether specific devices surpass dressings in terms of patient comfort, time required to maintain hemostasis, and vascular complications.

The primary goal of this study was to examine the effectiveness of compression dressings and hemostatic wristbands on patients undergoing cardiac procedures via radial approach in terms of patient comfort, time required to maintain hemostasis, and vascular problems.

The hemostatic wristband TR BandR (Terumo Corporation, Tokyo, Japan) was utilized in one group, while compressive elastic dressing, standardized as 13 threads gauze overlapped, opened, longitudinally pleated once and wrapped, making a 5-cm long cylinder, 1-cm in height, was used in the other.

Study Overview

Study Type

Interventional

Enrollment (Actual)

400

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nablus, Palestinian Territory, occupied
        • An-Najah National University Hospital
    • West Bank
      • Nablus, West Bank, Palestinian Territory, occupied, P4170051
        • An-Najah National University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age > 18 years
  • Patients who agree to participate in the study and sign the consent form.
  • Patients with an indication for coronary catheterization
  • Clinically stable patients
  • Patients with palpable pulses on at least one of the radial arteries.

Exclusion Criteria:

  • Patients who are hemodynamically unstable (systolic blood pressure less 90mmhg)
  • Patients with radial AV shunt for hemodialysis
  • Patients with previous CABG using radial artery
  • Patients with Renaud phenomenon or lymphedema
  • Patients who had vascular problems at the puncture site before the hemostasis process started.
  • Failure to obtain radial access

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Compressive Elastic dressing
Patients who received compressive elastic dressing as a hemostasis technique after coronary angiography using radial approach.
Following cardiac procedure using radial approach, compressive elastic dressing, standardized as 13 threads gauze overlapped, opened, longitudinally pleated once and wrapped, making a 5-cm long cylinder, 1-cm in height, fixed with elastic crepe bandage was used to achieve hemostasis.
Active Comparator: wristband TR Band
Patients who received wristband TR Band as a hemostasis technique after coronary angiography using radial approach.
Following cardiac procedure using radial approach, hemostatic wristband TR BandR (Terumo Corporation, Tokyo, Japan) was utilized was used to achieve hemostasis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compression "hemostasis" time
Time Frame: Up to 240 minutes after placement
The time from the placement of the hemostatic Wristband or Compressive dressing until its removal (when there's no blood oozing after removal), measured by minutes.
Up to 240 minutes after placement
Number of patient with Hematoma and Grade of hematoma
Time Frame: Within 24 hours after the procedure
It is defined by EASY hematoma scale.
Within 24 hours after the procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patient with Radial artery occlusion
Time Frame: Within 24 hours after the procedure
Radial artery patency was checked by evaluating radial pulse, capillary refill, hand color, temperature, and assessing the puncture site and hand for any hematoma or bleeding. In the event of an access site hematoma or any other ischemia sign, the patient will be sent to the radiology department for further assessment with radial artery Doppler.
Within 24 hours after the procedure
Ischemic changes to the hand
Time Frame: Within 24 hours after the procedure
It is noted by clinical features of pallor, absence of pulse, pain, cold, paresthesia or paralysis.
Within 24 hours after the procedure
Post-procedural pain
Time Frame: Within 24 hours after the procedure
Assessed by numerical rating scale (NRS) for pain, which is an 11 point subjective scale (0-10) where 0 refers for no pain, 1-3 for mild pain, 4-6 for moderate pain and 7-10 for severe pain.
Within 24 hours after the procedure
Number of patient with Radial Artery Occlusion on follow up
Time Frame: After 4 weeks of the procedure.
Radial artery patency was checked by evaluating radial pulse and Doppler Ultrasonography.
After 4 weeks of the procedure.
Patient satisfaction of the used compression methode Assessed by Likert scale for satisfaction
Time Frame: Within 24 hrs
Assessed by Likert scale for satisfaction , which is a 5 point subjective scale (1-5) where 1 refers for Not at all satisfied , 2 for slightly satisfied , 3 for moderately satisfied, 4 for Very satisfied and 5 for Extremely satisfied.
Within 24 hrs

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yunis A Daralammouri, An-Najah National University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2020

Primary Completion (Actual)

January 1, 2021

Study Completion (Actual)

May 1, 2021

Study Registration Dates

First Submitted

June 4, 2022

First Submitted That Met QC Criteria

June 7, 2022

First Posted (Actual)

June 8, 2022

Study Record Updates

Last Update Posted (Actual)

September 29, 2022

Last Update Submitted That Met QC Criteria

September 27, 2022

Last Verified

September 1, 2022

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myocardial Infarction

Subscribe